Literature DB >> 28454724

Protein Phosphatase 1α enhances renal aldosterone signaling via mineralocorticoid receptor stabilization.

Shunmugam Nagarajan1, Twinkle Vohra2, Johannes Loffing1, Nourdine Faresse3.   

Abstract

Stimulation of the mineralocorticoid receptor (MR) by aldosterone controls several physiological parameters including blood pressure, inflammation or metabolism. We previously showed that MR turnover constitutes a crucial regulatory step in the responses of renal epithelial cells to aldosterone. Here, we identified Protein Phosphatase 1 alpha (PP1α), as a novel cytoplasmic binding partner of MR that promotes the receptor activity. The RT-PCR expression mapping of PP1α reveals a high expression in the kidney, particularly in the distal part of the nephron. At the molecular level, we demonstrate that PP1α inhibits the ubiquitin ligase Mdm2 by dephosphorylation, preventing its interaction with MR. This results in the accumulation of the receptor due to reduction of its proteasomal degradation and consequently a greater aldosterone-induced Na+ uptake by renal cells. Thus, our findings describe an original mechanism involving a phosphatase in the regulation of aldosterone signaling and provide new and important insights into the molecular mechanism underlying the MR turnover.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ENaC; Kidney; Mdm2; Proteasome; Ubiquitin

Mesh:

Substances:

Year:  2017        PMID: 28454724     DOI: 10.1016/j.mce.2017.04.020

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211.

Authors:  Melanie Patt; Joël Gysi; Nourdine Faresse; John A Cidlowski; Alex Odermatt
Journal:  Mol Cell Endocrinol       Date:  2020-06-22       Impact factor: 4.102

2.  Huoxue Jiedu Huayu Formula Alleviates Cell Pyroptosis in Contralateral Kidneys of 6-Month-Old UUO Rats through the NLRP3/Caspase-1/IL-1β Pathway.

Authors:  Xuelian Ma; Panpan Qiang; Gege Chen; Zheng Wang; Xiangting Wang; Qingyou Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-12       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.